OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Icariin attenuates renal fibrosis in chronic kidney disease by inhibiting interleukin‐1β/transforming growth factor‐β‐mediated activation of renal fibroblasts
Meng Wang, Lingchen Wang, Yuan Zhou, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 11, pp. 6204-6215
Closed Access | Times Cited: 23

Showing 23 citing articles:

Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering
Zahra Seyedi, Mohammad Sadegh Amiri, Vahideh Mohammadzadeh, et al.
Journal of Functional Biomaterials (2023) Vol. 14, Iss. 1, pp. 44-44
Open Access | Times Cited: 37

Icariin exhibits protective effects on cisplatin-induced cardiotoxicity via ROS-mediated oxidative stress injury in vivo and in vitro
Juan Xia, Jun‐nan Hu, Ruobing Zhang, et al.
Phytomedicine (2022) Vol. 104, pp. 154331-154331
Closed Access | Times Cited: 24

Chinese herbal medicine and its active compounds in attenuating renal injury via regulating autophagy in diabetic kidney disease
Peng Liu, Wenhui Zhu, Yang Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16

Icariside Ⅱ attenuates bleomycin-induced pulmonary fibrosis by modulating macrophage polarization
Lingling Deng, Boshu Ouyang, Hanlin Shi, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116810-116810
Closed Access | Times Cited: 14

Shen-Shuai-II-Recipe inhibits tubular inflammation by PPARα-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys
Meng Wang, Lingchen Wang, Liang Zhou, et al.
Phytomedicine (2024) Vol. 126, pp. 155450-155450
Closed Access | Times Cited: 5

Exploration of the protective mechanisms of Icariin against cisplatin-induced renal cell damage in canines
Jiayi Liu, Liuwei Xie, Huiqi Zhai, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 3

Inflammation accelerating intestinal fibrosis: from mechanism to clinic
Shuzi Xin, Xiaohui Liu, Chengwei He, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3

Icariin, the main prenylflavonoid of Epimedii Folium, ameliorated chronic kidney disease by modulating energy metabolism via AMPK activation
Yudan Zhao, Wanyue Yang, Xin Zhang, et al.
Journal of Ethnopharmacology (2023) Vol. 312, pp. 116543-116543
Closed Access | Times Cited: 7

Mechanistic insights of clinically proven natural products in the treatment of hepatitis B focusing on clinical evidence and pathways
Anwar Parvez, Anand Kumar Das, Ashik Mahmud, et al.
Deleted Journal (2024), pp. 200183-200183
Open Access | Times Cited: 2

Epimedium sagittatum Maxim ameliorates adriamycin‐induced nephropathy by restraining inflammation and apoptosis via the PI3K/AKT signaling pathway
Ru Wang, Mengnan Zeng, Beibei Zhang, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 6

Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidation
Meng Wang, Jing Wang, Lingchen Wang, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 839-855
Closed Access | Times Cited: 4

Chinese botanical drugs targeting mitophagy to alleviate diabetic kidney disease, a comprehensive review
Leilei Ma, Jing Li, Xiaotian Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Icariin suppresses nephrotic syndrome by inhibiting pyroptosis and epithelial-to-mesenchymal transition
S Duan, Zhaoran Ding, Can Liu, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0298353-e0298353
Open Access | Times Cited: 1

Association between dietary intake of flavonoid and chronic kidney disease in US adults: Evidence from NHANES 2007-2008, 2009-2010, and 2017-2018
Peijia Liu, Wujian Peng, Feng Hu, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0309026-e0309026
Open Access | Times Cited: 1

A Comprehensive Review on Chemistry and Contribution of Chinese Herb Epimedium brevicornum Maxim in Medicine
Neetu Agrawal, Deepika Goyal, Dimple Bansal
Current Traditional Medicine (2023) Vol. 10, Iss. 4
Closed Access | Times Cited: 3

Icariin alleviates the apoptosis of chondrocytes in osteoarthritis through regulating SIRT‐1‐Nrf2‐HO‐1 signaling
Ying‐song Liu, Haobo Zhong, Wei‐le Liu, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 4
Closed Access

A therapeutic approach to identify leading molecules from natural products and therapeutic targets in CKD by network pharmacology
Yugant Krishnakumar Talati, Anil Bhanudas Gaikwad
PharmaNutrition (2024), pp. 100421-100421
Closed Access

Icariin and Competing Endogenous RNA Network: A Potential Protective Strategy Against Contrast-Induced Acute Kidney Injury
Yan Lin, Gaofeng Zhu, Xiaoyong Li, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 2343-2363
Open Access | Times Cited: 2

Shenxian-Shengmai Oral Liquid Evoke Autophagy of Fibroblast to Attenuate Sinoatrial Node Fibrosis in Sick Sinus Syndrome Mice via the AKT/mTOR Pathway
Chen Chen, Heng Zhang, Siyi Hou, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 2

Page 1

Scroll to top